Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Current Leases (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Current Leases for 3 consecutive years, with $139490.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 64.71% to $139490.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $139490.0 through Dec 2025, down 64.71% year-over-year, with the annual reading at $139490.0 for FY2025, 64.71% down from the prior year.
  • Current Leases for Q4 2025 was $139490.0 at bioAffinity Technologies, up from $136197.0 in the prior quarter.
  • The five-year high for Current Leases was $403584.0 in Q1 2025, with the low at $94708.0 in Q4 2023.
  • Average Current Leases over 3 years is $224380.5, with a median of $137843.5 recorded in 2025.
  • Peak annual rise in Current Leases hit 317.65% in 2025, while the deepest fall reached 64.88% in 2025.
  • Over 3 years, Current Leases stood at $94708.0 in 2023, then surged by 317.39% to $395301.0 in 2024, then tumbled by 64.71% to $139490.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $139490.0, $136197.0, and $133239.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.